P10 Inc (PX) concluded trading on Wednesday at a closing price of $13.40, with 0.44 million shares of worth about $5.93 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 51.41% during that period and on January 08, 2025 the price saw a gain of about 1.59%. Currently the company’s common shares owned by public are about 53.81M shares, out of which, 39.81M shares are available for trading.
Stock saw a price change of 6.26% in past 5 days and over the past one month there was a price change of 1.21%. Year-to-date (YTD), PX shares are showing a performance of 6.26% which increased to 50.22% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $7.08 but also hit the highest price of $14.28 during that period. The average intraday trading volume for P10 Inc shares is 669.58K. The stock is currently trading 2.92% above its 20-day simple moving average (SMA20), while that difference is up 5.36% for SMA50 and it goes to 33.27% higher than SMA200.
P10 Inc (NYSE: PX) currently have 53.81M outstanding shares and institutions hold larger chunk of about 35.56% of that.
The stock has a current market capitalization of $1.50B and its 3Y-monthly beta is at 1.11. PE ratio of stock for trailing 12 months is 132.02, while it has posted earnings per share of $0.10 in the same period. Its PEG reads 10.91 while making debt-to-equity ratio of 0.96. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PX, volatility over the week remained 2.96% while standing at 3.31% over the month.
Stock’s fiscal year EPS is expected to rise by 11.69% while it is estimated to increase by 5.84% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on January 07, 2025 offering an Overweight rating for the stock and assigned a target price range of between $14 and $15 to it. Coverage by UBS stated P10 Inc (PX) stock as a Neutral in their note to investors on August 21, 2024, suggesting a price target of $10.50 for the stock. On March 04, 2024, Morgan Stanley Downgrade their recommendations, while on March 01, 2024, Keefe Bruyette Downgrade their ratings for the stock with a price target of $10. Stock get a Neutral rating from JP Morgan on March 01, 2024.
